Clinical Trial Update: Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder [Phase 3]

View source ↗

Summary

Long-term extension results from a Phase 3 study of vortioxetine (Lu AA21004) in adults with major depressive disorder, focusing on safety and tolerability duri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• TRINTELLIX (Vortioxetine)

Snippet

Sponsor: Takeda | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED